Search
for
Sort by
Research 781–810 of 1000+
- Light‐Activatable Hyaluronic Acid‐Derivatives Releasing Nitric Oxide and Their Delivery in the Skin
- Cutaneous Adverse Drug Reactions (CADRs) to COVID19 vaccines: A case series
- Screening of dermatology drugs for aberrant use‐patterns: An application of epidemiologic estimates and measures of inequality in drug use
- Advancements in Drug Repurposing: Examples in Psychiatric Medications
- Nanoformulation of Medicinal Plant Compounds for Improved Drug Delivery and Pharmacological Activity
- Analysis of Adverse Drug Reactions in Pediatric Patients with Epilepsy: An Intensive Pharmacovigilance Study
- Application of the waiting time distribution in a nationwide screening of real‐world dermatology drug utilization for aberrant use patterns
- Cutaneous Adverse Drug Reactions to Antibiotics: How Much is the Extent of the Problem?
- Pharmacovigilance-based drug repurposing: searching for putative drugs with hypohidrosis or anhidrosis adverse events for use against hyperhidrosis
- US Food and Drug Administration Warning Regarding Finasteride and Suicidal Ideation: What Should Urologists Know?
- Methods and Challenges in Purifying Drug‐Loaded Extracellular Vesicles
- Remote loading of minoxidil in nano-reservoirs leads to polymorphism and controlled release
- An overview of current strategies and future prospects in drug repurposing in tuberculosis
- Multifunctional Hydrogel with Dual Functions of ROS Scavenging and Responsive Antibiotic Release for Synergistic Oral Mucositis Treatment
- Cytochrome P450: A Target for Drug Development for Skin Diseases
- In vivo promoted growth of mice hair follicles by the controlled release of growth factors
- Minoxidil is a potential neuroprotective drug for paclitaxel-induced peripheral neuropathy
- Turmeric Essential Oil Constituents as Potential Drug Candidates: A Comprehensive Overview of Their Individual Bioactivities
- Engineered Hair Follicle Mesenchymal Stem Cells Overexpressing Controlled-Release Insulin Reverse Hyperglycemia in Mice with Type l Diabetes
- Ranitidine and finasteride inhibit the synthesis and release of trimethylamine N-oxide and mitigates its cardiovascular and renal damage through modulating gut microbiota
- Hypertension: sex-related differences in drug treatment, prevalence and blood pressure control in primary care
- In vitro hair follicle growth model for drug testing
- ER71/ETV2 Promotes Hair Regeneration from Chemotherapeutic Drug-Induced Hair Loss by Enhancing Angiogenesis
- Management of Colorectal Cancer Using Nanocarriers-based Drug Delivery for Herbal Bioactives: Current and Emerging Approaches
- TWEAK-conjugated selenoviologen as a novel photosensitizer for selective wound accumulation and synergistic healing of drug-resistant bacterial infections
- Latest developments in the field of stem cell research and regenerative medicine compiled from publicly available information and press releases from nonacademic institutions, 1–30 September 2016
- The Post-finasteride Syndrome: Clinical Manifestation of Drug-Induced Epigenetics Due to Endocrine Disruption
- Morphological changes in human head hair subjected to various drug testing decontamination strategies
- Progress in the design of ascorbic acid derivative-mediated drug delivery
- Ultrasound-responsive hydrogel with ROS scavenging and NO controllable release capabilities for accelerated healing of diabetic wounds